July 2, 2010 - FDA Approves Prograf Generic

Watson Pharmaceuticals Inc. announced it received approval to sell a generic version of the drug Prograf [tacrolimus], which is used to prevent rejection of transplanted organs." The FDA approved the drug "in 5-milligram capsules," and Watson "said it will start shipping the drug immediately."